EXELIXIS, INC. — Director's Dealing 2019

Apr 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-04-03

Reporting Person: Schwab Gisela (Pres, Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-03	Common Stock	M	63109	$7.18	Acquired	379622	Direct
2019-04-03	Common Stock	S	63109	$25	Disposed	316513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-03	Option (right to buy)	$7.18	M	63109	Disposed	2019-12-08	Common Stock (63109.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14738	Indirect

Footnotes

F1: Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of April 2, 2019.

F4: The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013.